News Articles Tagged: Glycoengineering

The Impact of 2-Deoxy-2-fluoro-L-fucose on Therapeutic Antibody Development

Discover how 2-Deoxy-2-fluoro-L-fucose (CAS 70763-62-1) impacts therapeutic antibody development by enhancing ADCC. Find suppliers and pricing for this key intermediate.

Advancing Research with Metabolic Glycoengineering Tools: The Role of Ac4GalNAz

Discover how NINGBO INNO PHARMCHEM CO.,LTD.'s Ac4GalNAz serves as a key tool in metabolic glycoengineering for enhanced biological research.